| Description | Tanogitran, a coagulation factor Xa inhibitor, is used potentially for the treatment of septic shock. |
| Synonyms | BIBT 986, BIBT986, BIBT-986 |
| molecular weight | 477.56 |
| Molecular formula | C25H31N7O3 |
| CAS | 637328-69-9 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year |
| References | 1. Remko M, Remková A, Broer R. Theoretical Study of Molecular Structure and Physicochemical Properties of Novel Factor Xa Inhibitors and Dual Factor Xa and Factor IIa Inhibitors. Molecules. 2016 Feb 4;21(2). pii: E185. doi: 10.3390/molecules21020185. PubMed PMID: 26861270. 2. Aditya S. Oral and parenteral anticoagulants: new kids on the block. J Postgrad Med. 2012 Oct-Dec;58(4):275-85. doi: 10.4103/0022-3859.105448. Review. PubMed PMID: 23298923. 3. Gómez-Outes A, Suárez-Gea ML, Lecumberri R, Rocha E, Pozo-Hernández C, Vargas-Castrillón E. New parenteral anticoagulants in development. Ther Adv Cardiovasc Dis. 2011 Feb;5(1):33-59. doi: 10.1177/1753944710387808. Review. PubMed PMID: 21045018. |